Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Kennedy (D-Mass.) price & promotion investigations

Executive Summary

Senate Labor & Human Resources Committee may hold two days of hearings by early summer as a follow-up to the inquiries about marketing practices sent to industry last summer. In one-two punch, the first day is expected to focus on pharmaceutical marketing and promotion; the second on prices. The two-day format was very successful for Kennedy during his big investigation of the pharmaceutical industry in the mid-1970's. The chief investigator for the drug hearings is Walter Sheridan, one of the key investigators from the earlier round and a major player in the Jimmy Hoffa investigations in the early 1960's. Kennedy's staff is playing the dates and subjects of the hearings close to the vest. At his best, Kennedy used to spring the hearings, witness lists and questions on short notice.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel